U.S. pharma giant copyright scrapped two experimental weight loss supplements past year—a after-each day capsule, lotiglipron, as a consequence of elevated liver enzymes plus a two times-everyday tablet, danuglipron, as a consequence of sturdy Unwanted side effects—but CEO Albert Bou